European Pharma Days

Join Bruker for the annual European Pharma Meeting taking place on April 1^st - 2^nd 2025 organized by Bruker, M²Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy.

In this exciting 2-day event we have speakers from the pharmaceutical industry and academia discussing with you their strategies in Drug Targeting Approaches, Biomarker Discovery and Biopharmaceutical Characterization.

Take advantage of the opportunity to find out about the newest insights in the field of Metabolomics, Proteomics, MALDI Imaging and drug discovery. Do not miss the state-of-the-art scientific research presentations by Bruker customers.

The 2-day event is held in a safe, comfortable environment where you can meet and learn from the leading scientists in the pharmaceutical industry and academia. There is plenty of time for networking and discussion during the breaks, where you can engage with our partners in the exhibition area.

Reserve your free seat by clicking the registration link below.

Location:

MAFINEX Technologiezentrum
Julius-Hatry-Straße 1
68163 Mannheim, Germany

Day 1: Tuesday, April 1, 2025

10:30 Registration open

11:00 - 11:20 Opening
Angelika Altmann-Dieses, Ph.D., President, Mannheim University of Applied Sciences, Mannheim, Germany
Carsten Hopf, Ph.D., Professor, Head of CeMOS - Center for Mass Spectrometry and Optical Spectroscopy, Mannheim, Germany
Christian Albers, Ph.D., Business Development Manager, Pharmaceutical Markets, DACH/Nordics, Bruker Daltonics, Bremen, Germany

11:20 - 11:45 Advances in the design and function of the new timsOmni platform
Dimitris Papanastasiou, Managing Director, Fasmatech Science and Technology, Athens, Greece

11:45 - 12:10 Top-down sequencing of intact, modified proteins by timsTOF technology with new multimodal fragmentation capabilities
Ole Nørregard Jensen, Ph.D., Department of Biochemistry and Molecular Biology, Biomedical Mass Spectrometry and System Biology, University of Southern Denmark, Odense, Denmark

12:10 - 12:35 Development of a MALDI High-Throughput Assay for the Analysis of Protein Biopharmaceutical Quality Attributes 
Göran Hübner, Ph.D., Global Development CMC Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

12:35 - 14:05 Lunch Break

14:05 - 14:30 Tissue Mass Spectrometry Imaging at Sanofi: Insights and New Technological Applications for R&D Contribution
Bogdan Munteanu, Ph.D., Lab Head CoE Imaging Mass Spectrometry, R&D, Drug Metabolism & Pharmacokinetics, Sanofi-Aventis Deutschland GmbH

14:30 - 14:55 Exploring Anticancer Mechanisms of a Dual Arginase Inhibitor using MALDI Imaging
Yasemin Ucal, Ph.D., Scientific Project Manager EU-OPENSCREEN ERIC, Berlin

14:55 - 15:20 Bringing Mass Spectrometry Imaging to the Clinic: Standardization Insights from a Multi-Center Study  
Juliana Gonçalves, Ph.D., Postdoctoral Researcher, Institute of Pathology, TU Munich, Germany

15:20 - 16:00 Coffee Break

16:00 - 16:25 The drive towards integrated single cell metabo-proteomics 
Martin Forbes, Ph.D., Department for Proteomis and Metabolomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany

16:25 - 16:50 4D-Lipidomic assays for in-depth disease phenotyping
Laura Bindila, Ph.D., Head of Clinical Lipidomics Unit, University Medical Center Mainz, Germany

16:50 - 17:15 Kinetic characterization of therapeutic antibodies on cells using single-cell Interaction Cytometry
Johannes Mehringer, Ph.D., Research Group Leader, Kurt-Schwabe-Institute for Bioanalytical Systems, Meinsberg, Germany

17:15 - 17:40 A Hybrid Proteomics Approach Captures the Extent and Dynamics of Phosphorylation of AMP-activated kinase Complex
Boris Krichel, Ph.D., Leibniz Institute for Viroloy, Centre for Structural Systems Biology, Hamburg, Germany

17:40 - 18:40 Networking

Day 2: Wednesday, April 2, 2025

9:00 - 9:25 Mass Spectrometry Imaging: A multi-faceted tool to challenge precision medicine and surgery
Isabelle Fournier, Ph.D., Laboratoire PRISM - Unité Inserm 1192, Faculté des Sciences et Technologies, Départment de Biologie, Université de Lille, France

9:25 - 9:50 Mass-Guided Single-Cell MALDI Imaging of Low-Mass Metabolites Reveals Cellular Activation Markers
James-Lucas Cairns, M.Sc., Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

9:50 - 10:15 Decision-making applications of MALDI Imaging in Toxicologic Pathology
Heike Marxfeld, Ph.D., Senior Principal Scientist Veterinary Pathology, BASF, Ludwigshafen, Germany

10:15 - 10:55 Coffee Break

10:55 - 11:20 High-sensitive immunopeptidomics using timsTOF Ultra 2 for development of better, safer biotherapeutics
Elise Pepermans, Ph.D., CEO and Co-founder, Immunespec, Niel, Belgium

11:20 - 11:45 Multiplex quantification of non-canonical protein biomarkers in human CSF
Khader Awwad, Ph.D., DMPK Senior Scientist, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany

11:45 - 12:10 Advancing host-cell proteins monitoring and CHO proteome coverage for biopharma applications with trapped ion mobility spectrometry
Somar Khalil, Ph.D., Principal Scientist at GSK Vaccines in the Analytical Research and Development Department, Rixensart, Belgium

12:10 - 13:40 Lunch Break

13:40 - 14:05 Potency assessment of biologics using label-free MALDI-MS cell bioassays
Christian Graf, Ph.D., Senior Expert, Scientific Office Technical R&D Biologics, Novartis, Munich, Germany

14:05 - 14:30 MALDI-MS as a versatile tool in Alzheimer’s research: MALDI assays and imaging
Thomas Enzlein, Ph.D., Group Leader Bioinformatics, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

14:30 - 14:55 High-performance separation of mAb proteoforms by native CZE coupled to timsTOF MS under native and denaturing nanoESI conditions
Christian Neusüß, Ph.D., Institute for Analytical and Bioorganic Chemistry, Aalen, Germany

14:55 - 15:10 Wrap-up